Tumor Targeting of Mono-, Di-, and Tetravalent Anti-p185HER-2 Miniantibodies Multimerized by Self-associating Peptides

This publication has 29 references indexed in Scilit:

• Recombinant antibody constructs in cancer therapy
  Current Opinion in Immunology, 1999
• Antibodies come back from the brink
  Nature Biotechnology, 1998
• Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu
  British Journal of Cancer, 1998
• Diabodies: small bispecific antibody fragments
  Cancer Immunology, Immunotherapy, 1997
• New protein engineering approaches to multivalent and bispecific antibody fragments
  Immunotechnology, 1997
• High volumetric yields of functional dimeric miniantibodies in Escherichia coli , using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions
  Applied Microbiology and Biotechnology, 1996
• Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments
  British Journal of Cancer, 1996
• Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library
  Nature Medicine, 1996
• Engineered turns of a recombinant antibody improve its in vivo folding
  Protein Engineering, Design and Selection, 1995
• Tumor targeting in a murine tumor xenograft model with the (sFv′)2 divalent form of anti-c-erbB-2 single-chain Fv
  Cell Biochemistry and Biophysics, 1994